A new therapeutic approach to help adults quit smoking
Official title: Translational Development of a Novel Therapeutic for Tobacco Dependence
Funded at Flik Therapeutics, INC. · NIH-11453254 · Data updated 2026-11-12
A new treatment being developed to help adults stop smoking, including young adults, using a novel therapeutic approach.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Flik Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 15, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,649,843 |
| NIH project number | 1UG3DA067092-01 |
| Project ID | NIH-11453254 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years and older who smoke or vape and are seeking to quit could be eligible for future participation.
✕Less likely to help
People who are not nicotine users or who cannot quit with this approach may not benefit.
What this research studies
This grant focuses on developing a new therapy to help people 21 and older quit nicotine addiction from cigarettes and e-cigarettes. It describes moving a potential treatment from early development toward something that could be tested in people. The work is conducted by Flik Therapeutics in Philadelphia and involves a translational plan to bring a promising therapy closer to patients who want to quit nicotine. The project outlines how the therapy will be tested for safety and effectiveness as part of a structured development timeline.
Why it matters
Potential benefit: If successful, this therapy could provide a new option to help people quit nicotine dependence more effectively.
How similar studies have gone: Previous smoking-cessation approaches have had limited success, making new therapies potentially impactful if proven effective.
Where this research is happening
-
Flik Therapeutics, INC.
Philadelphia, United States Active
Researchers
- Principal investigator: Heiden, Brendan — Flik Therapeutics, INC.
- Study coordinator: Heiden, Brendan
Related research
Other NIH-funded projects on the same topics.
-
Motivational Interviewing and Mindfulness-Only Recovery for Tobacco and Other Drug Use in Methadone Treatment
A new program combines motivational interviewing and mindfulness-based therapy to help people on methadone treatment quit tobacco and other drugs at the same time.
-
Mindfulness and motivational coaching to help people on methadone quit smoking and reduce other drug use
This program offers group mindfulness training plus motivational coaching for people on methadone to help them stop smoking and cut down other drug use.
-
A mentoring program to improve tobacco dependence research.
This study is creating a mentoring program to help new researchers learn how to improve treatments for people trying to quit smoking, making sure they work well for different individuals based on their unique needs.
-
Helping people in methadone treatment quit smoking and other drugs
This study is looking for people in methadone treatment for opioid use who also smoke, to try out a new 8-week group program that teaches mindfulness and emotional skills to help them feel better and reduce their chances of relapsing into substance use.
-
Volitional Help Sheets to Support Smoking Cessation in Clinical Care
This pilot tests whether adding a short, personalized if-then planning tool helps people in a French clinic quit smoking when used alongside usual care.
-
Extended tobacco support for people experiencing homelessness
This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.